Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2025-12-24 @ 4:14 PM
Study NCT ID:
NCT06746766
Status:
RECRUITING
Last Update Posted:
2024-12-24
First Post:
2024-12-09
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Registry Study on Rare Cancers in Korea
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'OTHER'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 500}, 'targetDuration': '5 Years', 'patientRegistry': True}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2024-11-18', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2024-12', 'completionDateStruct': {'date': '2027-12-01', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2024-12-17', 'studyFirstSubmitDate': '2024-12-09', 'studyFirstSubmitQcDate': '2024-12-17', 'lastUpdatePostDateStruct': {'date': '2024-12-24', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2024-12-24', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2027-12-01', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Establish a registry', 'timeFrame': '1 year', 'description': 'Establish a registry of rare cancer patients visiting the institution'}], 'secondaryOutcomes': [{'measure': 'Clinical trial registration rate (%)', 'timeFrame': '1 year', 'description': 'Clinical trial registration rate (%)'}]}, 'oversightModule': {'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Rare Cancer'], 'conditions': ['Rare Cancer']}, 'referencesModule': {'references': [{'pmid': '20824452', 'type': 'BACKGROUND', 'citation': 'Gatta G, Capocaccia R, Trama A, Martinez-Garcia C; RARECARE Working Group. The burden of rare cancers in Europe. Adv Exp Med Biol. 2010;686:285-303. doi: 10.1007/978-90-481-9485-8_17.'}, {'pmid': '11905758', 'type': 'BACKGROUND', 'citation': 'Very rare cancers--a problem neglected. Lancet Oncol. 2001 Apr;2(4):189. doi: 10.1016/s1470-2045(00)00273-4. No abstract available.'}, {'pmid': '16919780', 'type': 'BACKGROUND', 'citation': 'Pritchard-Jones K, Kaatsch P, Steliarova-Foucher E, Stiller CA, Coebergh JW. Cancer in children and adolescents in Europe: developments over 20 years and future challenges. Eur J Cancer. 2006 Sep;42(13):2183-90. doi: 10.1016/j.ejca.2006.06.006.'}]}, 'descriptionModule': {'briefSummary': 'This study aims to determine the participation rate of patients with registered rare cancers in clinical research.', 'detailedDescription': 'Data collection includes:\n\n* Clinical characteristics (diagnosis, treatment information, primary/metastatic sites, staging, gender/age)\n* Survival information (diagnosis date, recurrence date, death date, disease progression)\n* Pathological information (diagnosis, genomic information)'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '19 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Data collection includes:\n\n* Clinical characteristics (diagnosis, treatment information, primary/metastatic sites, staging, gender/age)\n* Survival information (diagnosis date, recurrence date, death date, disease progression)\n* Pathological information (diagnosis, genomic information)', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Adults aged ≥19 years\n* Confirmed rare cancer\n* Life expectancy ≥3 months\n\nExclusion Criteria:\n\n-Serious or unstable medical/psychiatric conditions'}, 'identificationModule': {'nctId': 'NCT06746766', 'acronym': 'rarecancer', 'briefTitle': 'Registry Study on Rare Cancers in Korea', 'organization': {'class': 'OTHER', 'fullName': 'Yonsei University'}, 'officialTitle': 'Registry Study on Rare Cancers in Korea', 'orgStudyIdInfo': {'id': '4-2024-1207'}, 'secondaryIdInfos': [{'id': '4-2024-1207', 'type': 'OTHER', 'domain': 'Severance Hospital, IRB'}]}, 'contactsLocationsModule': {'locations': [{'zip': '03722', 'city': 'Seoul', 'status': 'RECRUITING', 'country': 'South Korea', 'facility': 'Severance Hospital', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}], 'centralContacts': [{'name': 'Hyo Song Kim, MD, Ph.D', 'role': 'CONTACT', 'email': 'hyosong77@yuhs.ac', 'phone': '82-2-2228-8124'}], 'overallOfficials': [{'name': 'Hyo Song Kim, MD, Ph.D', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Yonsei Cencer center'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Yonsei University', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Principal Investigator', 'investigatorFullName': 'Hyo Song Kim', 'investigatorAffiliation': 'Yonsei University'}}}}